Evolved AAV Capsids for Gene Therapy of CLN2 Disease

被引：0
|
作者：
Tecedor, Luis [1 ]
Chen, Yong Hong [1 ]
Ranum, Paul T. [1 ]
Megan, Keiser S. [1 ]
Leib, David E. [1 ]
Cheng, Congsheng [1 ]
Lysenko, Elena [1 ]
Davidson, Beverly L. [1 ]
机构：
[1] Childrens Hosp Philadelphia, Perelman Ctr Cellular & Mol Therapy, Philadelphia, PA USA
来源：
MOLECULAR THERAPY | 2022年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
266
引用
收藏
页码：128 / 129
页数：2
相关论文
共 50 条
  • [31] CLN2 disease-from early diagnosis early intervention
    Wibbeler, Eva
    Schulz, Angela
    MEDICINE, 2019, 98 (26)
  • [32] Generating Human-Evolved, Cell-Type-Specific AAV Capsids for Targeted Gene Delivery
    Belmar, Alba Guijarro
    Demosthenous, Panayiota
    Privolizzi, Riccardo
    Zinicola, Marta
    Luniak, Hanna
    Roberts, Brandon
    Parmar, Devan
    Smith, Calvin Chad
    Mathews, Miranda
    Murray, Andrew
    MOLECULAR THERAPY, 2024, 32 (04) : 267 - 268
  • [33] Interim results for RGX-381: a first in human phase 1/2 clinical trial of AAV.CB7.hCLN2 gene therapy for CLN2 Batten disease-associated retinopathy
    Henderson, Robert
    Gissen, Paul
    Prise, Katrina
    Vithlani, Ayeesha
    Cornelius, Sarah
    Roche, Dermot
    Thompson, Dorothy A.
    Buss, Nicholas
    Bailey, Alexander
    Paulo, Falabella
    Huang, Wei Chieh
    Burke, Jenna
    Ohnsman, Christina
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [34] Extraneuronal pathology in a canine model of CLN2 neuronal ceroid lipofuscinosis after intracerebroventricular gene therapy that delays neurological disease progression
    M L Katz
    G C Johnson
    S B Leach
    B G Williamson
    J R Coates
    R E H Whiting
    D P Vansteenkiste
    M S Whitney
    Gene Therapy, 2017, 24 : 215 - 223
  • [35] Tripeptidyl transferase (TPP-1) expression after intracerebral injections of AAV vectors harboring the CLN2 gene in monkeys.
    Redmond, DE
    Bjustad, KB
    Blanchard, B
    Sladek, JR
    Hackett, NR
    Sondhi, D
    Giannaris, EL
    Lam, M
    Peterson, DA
    Sanders, CT
    Kaminsky, SM
    Crystal, RG
    EXPERIMENTAL NEUROLOGY, 2003, 181 (01) : 103 - 104
  • [36] Loss of visual function associated with photoreceptor degeneration in CLN2 disease
    Ohnsman, Christina
    Huang, Wei Chieh
    Atiskova, Yevgeniya
    Wildner, Jan
    Falabella, Paulo
    Schulz, Angela
    Dulz, Simon
    MOLECULAR GENETICS AND METABOLISM, 2023, 138 (02) : 95 - 95
  • [37] CAP-001: Systemic AAV Gene Therapy with Next Generation Capsids for MPS II Disease
    Ou, Li
    Octeau, Christopher
    Bonet, Bailey
    Lam, Kevin
    Siemian, Justin
    Dreher, Renee
    Roxas, Kristina
    Jeffreys, David
    Thomas, Shelby
    Grepo, Nicole
    Sandrock, Robert
    Cockrell, Adam
    Scherrer, Jon
    Ressler, Reed
    Wheeler, Brandon
    Badger, Drew
    Knoll, Allison
    Goeden, Nick
    MOLECULAR THERAPY, 2022, 30 (04) : 223 - 223
  • [38] Speech, Language and Non-verbal Communication in CLN2 and CLN3 Batten Disease
    Morison, Lottie D.
    Whiteman, Ineka T.
    Vogel, Adam P.
    Tilbrook, Lisa
    Fahey, Michael C.
    Braden, Ruth
    Bredebusch, Joanna
    Hildebrand, Michael S.
    Scheffer, Ingrid E.
    Morgan, Angela T.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2025, 48 (01)
  • [39] Neurofilament light is a treatment-responsive biomarker in CLN2 disease
    Ru, Yuanbin
    Corado, Carley
    Soon, Russell K., Jr.
    Melton, Andrew C.
    Harris, Adam
    Yu, Guoying K.
    Pryer, Nancy
    Sinclair, John R.
    Katz, Martin L.
    Ajayi, Temitayo
    Jacoby, David
    Russell, Chris B.
    Chandriani, Sanjay
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2019, 6 (12): : 2437 - 2447
  • [40] ACTIVATION OF CLN1 AND CLN2 G(1) CYCLIN GENE-EXPRESSION BY BCK2
    DICOMO, CJ
    CHANG, H
    ARNDT, KT
    MOLECULAR AND CELLULAR BIOLOGY, 1995, 15 (04) : 1835 - 1846
12345